OPKO Health, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Alice Lin-Tsing Yu, M.D., Ph.D.”): 418,457,740 for, 45,287,103 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 45,336,237 for, 20,607,168 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Elias A. Zerhouni, M.D.”): 420,402,573 for, 42,561,617 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 44,653,646 for, 21,289,753 against, 7 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Gary J. Nabel, M.D., Ph.D.”): 420,083,341 for, 43,643,796 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 44,653,644 for, 21,289,760 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA

OPKO Health, Inc.’s own tally for this item (“Elect Director: Jane H. Hsiao, Ph.D.”): 422,928,151 for, 40,947,325 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 48,675,961 for, 17,267,443 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli

OPKO Health, Inc.’s own tally for this item (“Elect Director: John A. Paganelli”): 398,032,505 for, 65,734,019 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 33,875,961 for, 32,067,443 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Phillip Frost, M.D.”): 423,666,978 for, 40,175,942 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 48,656,294 for, 17,287,112 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Prem A. Lachman, M.D.”): 428,600,587 for, 35,002,548 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 48,675,354 for, 17,268,049 against, 3 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Richard C. Pfenniger, Jr.”): 424,416,857 for, 39,352,175 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 48,655,680 for, 17,287,725 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Roger J. Medel, M.D.”): 428,125,427 for, 35,411,814 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 48,675,351 for, 17,268,052 against, 3 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin

OPKO Health, Inc.’s own tally for this item (“Elect Director: Steven D. Rubin”): 409,356,877 for, 54,519,219 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 38,382,769 for, 27,560,636 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D.

OPKO Health, Inc.’s own tally for this item (“Elect Director: Subbarao V. Uppaluri, Ph.D.”): 454,992,813 for, 8,481,656 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 65,910,948 for, 32,454 against, 4 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: TO APPROVE THE COMPANY'S 2026 EQUITY INCENTIVE PLAN;

OPKO Health, Inc.’s own tally for this item (“Proposal 2: The stockholders voted to approve the Company's 2026 Equity Incentive Plan as disclosed in the Company's 2026 Proxy Statement for the Annual Meeting.”): 440,096,997 for, 23,694,041 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve the Company's 2026 Equity Incentive Plan as disclosed in the Company's 2026 Proxy Statement for the Annual Meeting.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 63,218,532 for, 2,724,871 against, 2 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: TO APPROVE A NON-BINDING RESOLUTION REGARDING THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS;

OPKO Health, Inc.’s own tally for this item (“Proposal 3: The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company's 2026 Proxy Statement for the Annual Meeting.”): 446,238,170 for, 17,487,326 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company's 2026 Proxy Statement for the Annual Meeting.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 44 managers: 65,890,328 for, 53,075 against, 3 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 148 managers: 78,953,331 for, 2,037,756 against, 45,200 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and

OPKO Health, Inc.’s own tally for this item (“Proposal 4: The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 535,070,921 for, 6,120,699 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 65,943,374 for, 27 against, 5 abstained.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.